University of Toronto and McMaster University-founded glioblastoma Car T-cell therapy developer Empirca Therapeutics has been acquired by Century Therapeutics.

University of Birmingham's cancer immunotherapy developer Revitope Oncology secured equity funding as part of a $160m alliance with Junshi Biosciences.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The online employee and further education provider has listed on TSE’s Mothers Market, allowing Tokyo Institute of Technology to exit.

The investment firm saw its portfolio net value decrease but said assets under management had risen by more than 50% during the 2019-2020 financial year.

GV and In-Q-Tel joined Greylock Partners in the first announced funding round for Snorkel AI, a machine learning development spinout from Stanford.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Neil Woodford has reportedly joined former WIM chief executive Craig Newman at Juno Capital to form a portfolio of unquoted healthcare stocks.

MIT-founded biochemical water treatment company Solugen has increased its funding total to at least $48.7m.

The second quarter total is up from $185m the previous year and $392m quarter-on-quarter despite coronavirus-driven pressures.